Navigation Links
Clinical Outsourcing Leaders Summit Set to Convene November 13
Date:10/2/2008

WASHINGTON, Oct. 2 /PRNewswire-USNewswire/ -- The Association of Clinical Research Organizations (ACRO) is pleased to announce it will convene the inaugural Clinical Outsourcing Leaders Summit with a select group of senior pharmaceutical, biotech and clinical research executives November 13, 2008 in Washington, DC.

This exclusive event will feature high-level, interactive discussions surrounding the impact of the presidential election on biomedical research and various aspects of drug development. Among the featured speakers are:

Dr. Mark B. McClellan, Senior Fellow and Director of The Engelberg Center for Healthcare Reform at the Brookings Institution and former commissioner of the Food and Drug Administration;

Bill Thomas, former U.S. Congressman and former Chairman of the House Committee on Ways and Means. Currently a Senior Advisor to Buchanan, Ingersoll & Rooney PC and a Visiting Fellow at the American Enterprise Institute;

Dr. Andrew Dahlem, Vice President and COO, Eli Lilly Laboratories;

Dr. Janet Woodcock, Director, Center for Drug Evaluation and Research at the Food and Drug Administration;

Ken Getz, founder and chairman of the nonprofit CISCRP and a Senior Research Fellow at the Tufts Center for Drug Development, Tufts University Medical School;

Chris Singer, Executive Vice President and COO of PhRMA;

David Spaight, Chair of the ACRO Board of Directors and President of MDS Pharma Services;

Dr. Dennis Gillings, founding Chair of ACRO and Chairman and CEO of Quintiles Transnational Corp.

"Regardless of the outcome of the November elections, we know the drug development industry will face significant changes in the coming years," said ACRO Executive Director, Doug Peddicord, Ph.D. "This summit will bring together thought leaders from the biopharmaceutical and clinical outsourcing industries for an open dialogue on the political, economic and regulatory aspects of the changing healthcare landscape."

The Clinical Outsourcing Leaders Summit is open to ACRO members and invited senior executives from the pharmaceutical and biotech industries. To inquire about participating, please contact Jonathan Jagoda at 202.543.4018.

About ACRO

The Association of Clinical Research Organizations (ACRO) is the professional organization of companies whose focus is clinical research. The association provides an active voice for the CRO industry, which provides specialized services that are integral to the development of drugs, biologics, and medical devices. ACRO helps its members improve the quality, efficiency, and safety of biomedical research. For more information, please visit http://www.acrohealth.org.

CONTACTS: Media

John Lewis

+1 202.285.5726

Industry

Jonathan Jagoda

+1 202.543.4018


'/>"/>
SOURCE Association of Clinical Research Organizations
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Jefferson awarded multi-million dollar grant from National Eye Institute for new clinical trial
2. MultiVu Video Feed: NEW RESEARCH PUBLISHED IN THE AMERICAN JOURNAL OF CLINICAL NUTRITION FINDS PISTACHIOS IMPROVE RISK FACTORS FOR HEART DISEASE
3. What is the clinical features of primary aortoenteric fistula?
4. Medicare HMO costs may prevent cancer patient clinical trial participation
5. DIA Conference to Present Latest Strategies in Clinical Trial Disclosure Compliance
6. Novel tuberculosis vaccine in Germany in clinical phase
7. Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model
8. Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development
9. VCU Massey Cancer Center spearheads novel clinical study for lymphoma patients
10. Shaping Best Practices For Standardized Medical Imaging In Clinical Trials
11. New probe to detect skin cancer receives more funding for clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... WI (PRWEB) , ... July 25, 2017 , ... ... Aloria Health, as medical director. Dr. Negrette has more than a decade of ... She has worked closely with individuals fighting addictions, eating disorders, psychotic and manic ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... Engineers at ... bio-compatible, because it produces the same kind of electrical energy that the body uses. ... form of moving electrons. This flow of electrons out of the battery is generated ...
(Date:7/24/2017)... ... 24, 2017 , ... Cosmetic Town, an online plastic surgery information community, announces ... on a daily basis. , The new video series will feature board-certified doctors ... their practices. , When asked about the new video series, the senior editor ...
(Date:7/24/2017)... ... July 24, 2017 , ... Peruvian Ayahuasca retreat, East ... awarded annually to and divided between two full-time university students enrolled in U.S. ... plant medicine. To apply for the scholarship, students are asked to submit an ...
(Date:7/24/2017)... ... July 24, 2017 , ... The Topricin Companies, formerly ... for Topricin’s revolutionary, natural, after-burn skin care product, Topricin After Burn Cream. ... long term skin conditions, including cancer. In the short term, overexposure to ...
Breaking Medicine News(10 mins):
(Date:7/14/2017)... 2017 It should come as no surprise to ... in the midst of a crippling opioid epidemic. According to ... number of overdose deaths from opiate-based medications has quadrupled, Says, ... million dead from 2001 to 2015". During this time, the ... similarly quadrupled, drawing a compelling link between prescription and eventual ...
(Date:7/12/2017)... CarpalAID is a revolutionary new product that relieves painful ... Carpal tunnel syndrome affects more than 8 million people a year. ... men. The common methods of treating CTS are painful surgery, the ... or gloves. ... CarpalAID is a clear patch worn on the palm of ...
(Date:7/11/2017)... Md. , July 11, 2017  The global ... estimated revenues of approximately $394.1 million in 2016.  Although ... trend of solid growth, in particular as a result ... clinical practice, and the recent introduction of a significant ... need for less-invasive testing of tumor biomarkers to guide ...
Breaking Medicine Technology: